http://www.globalchange.com Future trends in the pharmaceutical industry. Lack of innovation in pharma companies and empty product pipeline. Generic competition and product recalls. Drug development and novel substances. Large molecule and small molecule therapeutics. Risk profiles and clinical trials. Side effects, gene profile typing and pharmacogenomics. Health care, wellness, enhanced performance and lifestyle drugs. Patent expiry and intellectual property protection. Legal challenges and research scandals. Biogenerics and large molecule therapeutics. Cellular mechanisms of disease. Unmet needs. Government purchasing policies, future of medicare and health insurance cover. Online pharmacy price pressures. Over the counter and pharmacists - pharmacy products. Neutraceuticals and cosmetics. Search for new treatment blockbusters. Chronic disease, childhood disease, vaccines and orphan therapies. Rheumatoid and asthma. Antibiotics and multiple drug resistance problems. Search for powerful antiviral therapy. Future health funding and ageing populations. Contrast with emerging markets. Health economics: treatment access and justice issues. Pharmacogenomics and gene prophecy. Ethical issues in pharmaceuticals. HIV and AIDS. Patrick Dixon, conference keynote speaker and futurist.
<< Back to article
